SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer-killing virus plus immune booster shows promise for rare skin tumors
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't responded to standard care. First, patients receive a virus-based therapy (talimogene laherparepvec) that infects and kills tumor cells. Then, they also get an immunotherapy …
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Promising combo tackles tough head and neck cancers
Disease control OngoingThis study tests a combination of an immunotherapy drug (cemiplimab) and low-dose chemotherapy (paclitaxel and carboplatin) in 46 people with head and neck cancer that has returned or spread. The goal is to see if this mix can shrink tumors better than current treatments. Partici…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 19, 2026 11:52 UTC